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Aims An association has been described between death from arrhythmia and early repolarization, an electrocardiogram
pattern characterized by elevation of the QRS–ST junction (J-point). Little is known about this relationship in
non-white populations. This study examines the relationship between J-point elevation (JPE) and sudden cardiac
death (SCD) and whether this relationship differs by race or sex.
Methods
and results
A total of 15 141 middle-aged subjects from the prospective, population-based Atherosclerosis Risk in Communities
(ARIC) study were included in this analysis. The primary endpoint was physician-adjudicated SCD occurring from
baseline (1987–1989) through December 2002, secondary endpoints were fatal and non-fatal coronary events
and all-cause mortality occurring through December 2007. J-point elevation was defined as J-point amplitude
≥0.1 mV. Pre-specified subgroup analyses by sex and race were conducted. J-point elevation in any lead was
present in 1866 subjects (12.3%). After adjustment for demographic, clinical, lifestyle, and laboratory variables, JPE
was not significantly related to SCD in the overall sample [adjusted hazard ratio (HR), 1.23; 95% confidence interval
(CI), 0.87–1.75]. However, significant interactions were present between race and JPE (P ¼ 0.006) and between sex
and JPE (P ¼ 0.020). J-point elevation was significantly predictive of SCD in whites (adjusted HR, 2.03; 95% CI, 1.28–
3.21) and in females (adjusted HR, 2.54; 95% CI, 1.34–4.82).
Conclusion Our results suggest that JPE is associated with an increased risk of SCD in whites and in females, but not in blacks or
males. Further studies are needed to clarify which subgroups of individuals with JPE are at increased risk for adverse
cardiac events.
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Introduction
Sudden cardiac death (SCD) accounts for more than half of all
deaths from cardiovascular disease.1 – 3 Coronary heart disease
(CHD) underlies 80% of SCD cases, and SCD is the first mani-
festation of heart disease in 50% of these individuals.2,4 In most
cases, SCD is thought to be caused by cardiac arrest from
ventricular arrhythmia. Identification of individuals at increased
risk of SCD may allow targeted prevention strategies.
Although traditionally viewed as benign, several case–control
studies have suggested that the electrocardiogram (ECG) finding
of early repolarization may be associated with the development
of ventricular arrhythmia.5 –7 Characterized by elevation of the
QRS–ST junction (the J-point) above baseline on ECG, early
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repolarization is seen in 1–13% of people.8 –12 Recently, two
population-based studies showed that early repolarization was
associated with an increased risk of death from cardiac causes.10,11
These are the only population-based studies on the topic of
which we are aware, but they are limited by samples comprised pre-
dominantly of individuals of European descent. Importantly, blacks
may have a higher prevalence of the early repolarization pattern
and may be more likely to experience SCD.1,5,8,13,14
The early repolarization pattern has many morphological var-
iants.15 A considerable degree of subjectivity is involved in the diag-
nosis of early repolarization, and no consensus criteria currently
exist for its diagnosis. J-point elevation (JPE) is the central feature
of the early repolarization pattern. Like early repolarization, it has
been found in some studies to be more common in blacks.16,17 Exam-
ination of JPE specifically is advantageous in that it can be determined
from computerized ECG coding programs and can thus provide a
quantitative, objective measurement of ST-segment deviation,
making it useful in large epidemiological studies.
The goals of this study were therefore to estimate the preva-
lence of JPE in a large middle-aged biracial cohort of US adults
and to examine the association of JPE with risk of cardiac events
and whether the prognostic significance of the finding varies by
race or sex. Specifically, we investigated the association of JPE
with SCD, fatal/non-fatal CHD events, and all-cause mortality.
Methods
Study population
The Atherosclerosis Risk in Communities (ARIC) study18 is a prospec-
tive, population-based cohort study designed to investigate the aetiol-
ogy and natural history of cardiovascular disease. From 1987 to 1989,
ARIC investigators used probability sampling to enroll 15 792 men and
women aged 45–64 residing in four US communities: Jackson, MS;
Washington County, MD; Forsyth County, NC; and the northwestern
suburbs of Minneapolis, MN.
For the present analysis, we excluded 202 subjects for whom J-point
amplitude data were missing or incomplete. We also excluded 604
subjects with a QRS complex duration of ≥120 ms in order to
remove cases of bundle branch block, the Wolf–Parkinson–White
syndrome, and idioventricular rhythm. Additionally, 48 subjects were
excluded for race other than black or white. These exclusion counts
are not mutually exclusive. After the above exclusions, 15 141 subjects
remained for analysis.
Baseline measurements
At the baseline examination, a standard, resting, supine 12-lead ECG
was obtained for each subject a minimum of 1 h after any smoking
or caffeine ingestion. An electrode locator was used to determine
and standardize the positioning of chest electrodes. Tracings were
sent via a phone modem to be computer coded at the ARIC ECG
Reading Center. All records with significant Minnesota Code19 findings
as determined by the computer, as well as a random sample of tra-
cings, were sent to the ECG coding centre to be visually coded. Dis-
crepancies between the computer code and visual code were
adjudicated by a senior coder. Later processing of the ECGs took
place at EPICARE (Epidemiological Cardiology Research Center at
Wake Forest University, Winston-Salem, NC, USA), where the 2001
version of the GE Marquette 12-SL program was used to automatically
obtain ST amplitude at the J-point in relation to the isoelectric line.
J-point elevation was defined as a J-point amplitude of ≥0.1 mV
(1 mm) in any lead. Left ventricular hypertrophy (LVH) was assessed
by Cornell’s voltage criteria.20
Body mass index (BMI) in kg/m2 was calculated based on measured
height and weight. Fasting blood samples were analysed for lipid levels
and chemistry. Diabetes was defined as a fasting glucose level of
≥126 mg/dL, a non-fasting level of ≥200 mg/dL, self-reported phys-
ician diagnosis of diabetes, or pharmacological treatment for diabetes.
Information regarding race, smoking history, physical activity, family
health history, and educational attainment was obtained through inter-
views. Physical activity was based on the reported level of sport activity
using the Baecke physical activity questionnaire.21
Follow-up
The primary outcome was physician-adjudicated SCD. All cases pre-
viously categorized as fatal CHD that occurred in ARIC before 31
December 2002 were reviewed by a committee of physicians. Case
information was sent separately to pairs of physician adjudicators
using a standard coding form. When there was disagreement in the
classification, the case was re-coded by paired investigators. If
further disagreement occurred, it was resolved by discussion
between these coders. After review of data from death certificates,
informant interviews, physician questionnaires, coroner reports, and
hospital discharge summaries, reviewers classified each CHD death
as definite SCD, possible SCD, or non-sudden CHD death. Sudden
cardiac death was defined as a sudden pulseless condition of cardiac
origin in a previously stable individual. Because the ARIC study
enrolled individuals aged 45–64 years at baseline, the SCD seen in
this study will be primarily the atherosclerotic type, which accounts
for the majority of the SCD burden.
In general, the adjudication committee made use of death within
,1 h and within ,24 h criteria for witnessed and unwitnessed
events, respectively, but additionally used data on the circumstances
of death and body position in classification. Only cases of definite
SCD were included in the present analysis.
Secondary outcomes included fatal/non-fatal CHD events and all-
cause mortality. A fatal/non-fatal CHD event was defined as a definite
or probable myocardial infarction (MI) or definite CHD death.18
Events occurring between the baseline examination and 31 December
2007 were included in analysis of all outcomes with the exception of
SCD, for which the end of follow-up was 31 December 2002.
Statistical analysis
We used Cox’s proportional hazards models to obtain multivariate-
adjusted hazard ratios (HRs) for all study outcomes for subjects with
vs. those without JPE. We used an overall measure of JPE in any ECG
lead and also grouped the leads into anterior (V1–V5), inferior (II, III,
aVF), and lateral (I, aVL, V6) leads. Results are reported as HRs with
95% confidence intervals (CIs). Censoring occurred at the time of an
event, death, loss to follow-up, or at the end of follow-up.
Potential covariates included in the initial model were: age, sex, race,
BMI, heart rate, systolic blood pressure, smoking status, high-density lipo-
protein level, low-density lipoprotein level, diabetes, level of physical
activity, field centre, family history of premature CHD, LVH, serum elec-
trolyte levels, and presence of major ECG abnormality on Minnesota
Code.19 We also included data on prevalent CHD (including MI deter-
mined by self-report or ECG, self-report of heart or arterial surgery,
coronary bypass, balloon angioplasty, coronary artery angioplasty) and
on physician-diagnosed stroke, angina, and intermittent claudication as
ascertained by the Rose questionnaire.22 The following cardiac medi-
cations were also initially included as covariates: digitalis, selective and
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non-selective b-blockers, calcium channel blockers, angiotensin-
converting enzyme (ACE)-inhibitors, and antiarrhythmic drugs.
Variables found not to be related to JPE in bivariate analysis were
dropped from the full model in a stepwise fashion, and the resulting
reduced models were tested against the full model using the likelihood
ratio test. Tested variables that did not significantly affect results were
dropped from the model. Using this method, we created a set of
reduced models fit to JPE in any lead as the main exposure and
SCD as the outcome. This same set of covariates was then employed
across all exposures and all outcomes in order to enhance comparabil-
ity and reproducibility. Model 1 adjusts for demographic factors. Model
2 adjusts for demographic and clinical variables. Model 3 adjusts for
demographic, clinical, lifestyle, and laboratory variables. The pro-
portional hazards assumption was tested for each model using the
test of the Schoenfeld residuals.
We also undertook pre-specified subgroup analyses by race and sex.
We tested for the presence of interactions between race and JPE and
between sex and JPE individually using the likelihood ratio test. When a
significant interaction was present, we calculated HRs for the sub-
groups individually using coefficients from models with the pertinent
interaction term(s) included. The effects of race and sex on the risk
associated with JPE were also examined simultaneously. Finally, we
examined the data for the presence of an interaction between personal
history of CHD and JPE.
Statistical analyses were performed using STATA 11.0 (Stata Corp.,
College Station, TX, USA). All reported P-values are two-sided, with a
P-value of ,0.05 considered to indicate statistical significance.
This secondary analysis was exempted from full review by the Office




Overall, the sample was 44.3% males and 26.9% blacks (Table 1).
However, among subjects with JPE, 76.1% were males and 53.3%
were blacks. Subjects with JPE also had lower BMI, lower heart
rate, and higher blood pressure. They were more likely to be
smokers (34.1 vs. 25.0%, P , 0.001), to have LVH (6.0 vs. 1.3%,
P , 0.001), and to have a major Minnesota Code abnormality on
ECG (14.5 vs. 8.6%, P , 0.001). Those with JPE were more likely
to have a personal history of CHD or other vascular disease,
but were less likely to have a family history of premature CHD.
See Supplementary material online, Table S1, for baseline charac-
teristics of subjects who subsequently experienced SCD compared
with those who did not.
Prevalence of J-point elevation
J-point elevation was present in 1866–15 141 subjects (12.3%).
Elevation in the anterior leads (V1–V5) was found in 1767 subjects
(11.7%). Elevation in the inferior leads (II, III, aVF) was found in 119
subjects (0.8%), and 92 subjects (0.6%) had elevation in the lateral
leads (I, aVL, V6). Males were more likely than females to have JPE
in at least one lead (21.2 vs. 5.3%, P , 0.001; Figure 1). Prevalence
of JPE among blacks was higher than that among whites (24.4 vs.
7.9%, P , 0.001). J-point elevation was significantly more
common among younger subjects (13.1%) than among older
subjects (11.5%, P ¼ 0.003).
Overall risk of death and cardiac
outcomes
After a mean follow-up of 17+4 years (13+2 years for SCD),
3555 subjects (23.5%) died. Of these deaths, 237 (6.7%) were
adjudicated as SCD. During follow-up, 1764 subjects experienced
confirmed fatal or non-fatal CHD events. Of these events, 339
were fatal CHD, 105 were fatal MI, and 1320 were non-fatal MI.
In unadjusted analysis, subjects with JPE in any lead were 2.3
times more likely to suffer SCD than were subjects without JPE
(adjusted HR, 2.28; 95% CI, 1.69–3.07; Table 2). Statistically signifi-
cant relationships were also present between JPE in any lead and
secondary outcomes in unadjusted analysis. After adjustment for
race, sex, and age, JPE in any lead was no longer significantly
related to SCD (adjusted HR, 1.31; 95% CI, 0.94–1.82), and HRs
for secondary outcomes approached the null. Upon further adjust-
ment for clinical, lifestyle, and laboratory variables in addition to
demographic factors, these relationships remained non-significant.
See Supplementary material online, Table S2, for data on the risk
associated with the presence of JPE in the various lead groupings
(anterior, lateral, and inferior).
Among subjects with JPE in any lead, a significant interaction was
present between race and JPE for the primary outcome of SCD
(Table 3). Whites with JPE had a higher risk of SCD (adjusted HR,
2.03; 95% CI, 1.28–3.21) than did whites without JPE. However,
JPE did not confer an increased risk of SCD among blacks (adjusted
HR, 0.82; 95% CI, 0.52–1.30). The ratio of HRs for whites compared
with blacks was 2.46, indicating a large difference between these
groups in the risk associated with JPE. The interaction between JPE
and race was not significant for the secondary outcomes.
A significant interaction between sex and JPE was also present.
J-point elevation was associated with significantly increased risk of
SCD in females (adjusted HR, 2.54; 95% CI, 1.34–4.82). However,
JPE was not a marker of increased risk of SCD in males (adjusted
HR, 1.02; 95% CI, 0.69–1.50). The ratio of HRs for females com-
pared with males for SCD was 2.50, indicating that JPE connotes a
much greater risk of SCD in females than it does in males. J-point
elevation was also associated with a significantly increased risk of
fatal/non-fatal CHD events in females, but not in males. No signifi-
cant interaction was found between sex and JPE for all-cause mor-
tality. Absolute event rates can be found in Table 4.
Given that the relationship between JPE and SCD differed based
on race and sex, the four subgroups (white males, white females,
black males, and black females) were examined separately. White
females were found to have a significantly increased risk of SCD
when JPE was present (adjusted HR, 8.77; 95% CI, 3.19–24.13;
Table 5). Figures 2 and 3 show the Kaplan–Meier curves for SCD
in subjects with JPE stratified by race and sex simultaneously.
No significant interaction between personal history of CHD and
JPE was found for any of the outcomes, meaning that the risk for
cardiac events associated with JPE did not differ significantly
between those with and those without a personal history of CHD.
Discussion
Our study suggests that JPE in any lead in whites and in females is
associated with an increased risk of SCD. This finding has, to our
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Table 1 Baseline subject characteristics for overall sample and by J-point elevation status
Subject characteristics Overall sample (n 5 15 141),
mean (SD) or %
J-point elevation (n 5 1866),
mean (SD) or %
No J-point elevation (n 5 13 275),
mean (SD) or %
P-valuea
Age (years) 54.1 (5.8) 53.7 (5.8) 54.1 (5.7) 0.005
Sex
Male (%) 44.3 76.1 39.8 ,0.001
Female (%) 55.7 23.9 60.2
Race
White (%) 73.1 46.7 76.8 ,0.001
Black (%) 26.9 53.3 23.1
Body mass index (kg/m2) 27.7 (5.4) 26.6 (4.7) 27.9 (5.4) ,0.001
Heart rate (b.p.m.) 66.8 (10.4) 64.7 (10.7) 67.0 (10.3) ,0.001
Systolic blood pressure
(mmHg)
121.2 (18.8) 125.1 (21.9) 120.7 (18.3) ,0.001
Diastolic blood pressure
(mmHg)
73.7 (11.2) 76.9 (12.9) 73.3 (10.9) ,0.001
Smoking status
Current smoker (%) 26.1 34.1 25.0 ,0.001
Former smoker (%) 32.1 33.5 31.9
Never smoker (%) 41.8 32.4 43.1
Diabetic (%) 11.9 13.7 11.6 0.008
LVH by Cornell’s criteria (%) 1.9 6.0 1.3 ,0.001
Cornell’s voltage (mV) 1216 (531) 1388 (717) 1192 (494) ,0.001
Major abnormality
on ECGb (%)
9.5 14.5 8.6 ,0.001
High-density
lipoprotein (mg/dL)
51.7 (17.1) 51.4 (17.2) 51.7 (17.1) 0.42
Low-density
lipoprotein (mg/dL)
137.4 (39.4) 136.8 (40.6) 137.5 (39.2) 0.42
Education
Basic (%) 23.6 31.7 22.4 ,0.001
Intermediate (%) 40.9 32.7 42.0
Advanced (%) 35.6 35.6 35.6
Personal history of CHD (%) 4.6 7.1 4.2 ,0.001
History of stroke (%) 1.7 2.6 1.6 0.001
Angina (%) 5.0 3.6 5.2 0.004
Intermittent claudication (%) 0.77 0.75 0.77 0.93
Family history of premature
CHD (%)
10.3 7.6 10.6 ,0.001
Cardiac medications (%)
b-Blockers 10.7 10.1 10.8 0.38
Calcium channel blockers 3.40 3.80 3.34 0.31
Antiarrhythmics 0.65 0.94 0.61 0.11
Digitalis 1.46 1.49 1.45 0.91
ACE-inhibitors 3.05 3.47 2.99 0.26
Serum potassium (mmol/L) 4.42 (0.48) 4.41 (0.47) 4.42 (0.48) 0.55
Serum sodium (mmol/L) 141.0 (2.4) 140.9 (2.5) 141.0 (2.4) 0.73
Serum calcium (mg/dL) 9.79 (0.43) 9.81 (0.45) 9.78 (0.43) 0.003
Serum magnesium (mg/dL) 1.63 (0.16) 1.62 (0.16) 1.63 (0.16) ,0.001
aSignificance tests for comparisons by J-point elevation status based on two-sample t-test for continuous subject characteristics and Pearson’s x2 test for categorical subject
characteristics.
bMajor ECG abnormality as defined by Minnesota Code.
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knowledge, not been previously discussed in the literature. A trend
towards increased risk associated with JPE in whites and females
was observed across the secondary outcomes, though the differ-
ences between groups were not uniformly significant.
Several explanations could account for the observed difference
in risk between groups. The possibility exists that subtle physiologi-
cal differences are responsible for the discrepancies in risk. Simi-
larly, JPE could be a single phenotypic manifestation of a diverse
array of genotypes.23 These genotypic variations may be differen-
tially distributed between various racial groups. Some genotypes
may increase risk of poor outcomes, whereas others may be com-
pletely benign while producing similar ECG findings. Additionally,
the possibility exists that in some patients JPE may indicate under-
lying structural heart disease. Some instances of JPE may be due
not to early repolarization, but instead to delayed depolarization,
similar to that seen in periinfarction block.24 This pattern can be
seen in the setting of prior MI, LVH, latent ischemic heart
disease, and other forms of structural heart disease, all of which
could themselves be risk factors for SCD. Although we controlled
for the presence of major ECG abnormalities, which should
include most instances of periinfarction block, this point is
worth noting.
Alternatively, race- and sex-based differences could be attribu-
table to the use of a single ECG cut-off across both races and
sexes. The normal distributions of various ECG findings were orig-
inally obtained from samples of white males. We have since
become aware of the need to use different cut-offs for ‘abnormal-
ity’ based on the characteristics of the individual patient. For
example, clinicians now often use different cut-offs for defining
LVH in males and females. Several studies have shown that the
LVH criteria that are used clinically are of limited utility in
blacks.25,26 Perhaps, we are seeing risk discrepancies not due to
differences in underlying pathophysiology, but because of a need
for more accurate race- and sex-based norms. It is possible that
a certain degree of JPE is a normal finding in blacks and in males,
but that the presence of JPE in a female or a white individual
may indicate a more pronounced underlying abnormality,
whether it be structural or electrical. This concept makes intuitive
sense given the fact that JPE is more prevalent in blacks and in
males, but was not shown in our study to be associated with an
increased risk of SCD in these groups.
Consistent with past studies that examined the closely related
early repolarization pattern,10,17 our study found that JPE was
associated with male sex, black race, younger age, and lower
heart rate. Several case–control studies have reported a higher
prevalence of early repolarization among survivors of idiopathic
ventricular fibrillation (VF).5,6 Another case–control study found
that JPE was more common among survivors of primary VF.7 A
more recent population-based study found that early repolariza-
tion in the inferior leads, defined as JPE ≥ 0.1 mV, was a marker
of increased risk of death from cardiac causes and of sudden
death from arrhythmia.10 Finally, a case–cohort study conducted
in Germany showed an increased risk of cardiovascular mortality
in individuals manifesting the early repolarization pattern.11
In all of these studies, race was either not reported or predomi-
nantly white. No subgroup analyses based on sex were reported.
The sex- and race-based differences present in our study were
not obvious upon examination of the overall HRs, but during the
pre-specified subgroup analysis by race and sex, these relationships
became evident. Even though these interactions were not uni-
formly significant across all outcomes, there was a trend towards
Figure 1 Prevalence of J-point elevation in various subgroups.
P-values for comparisons between subgroups are all ,0.05; sig-
nificance tests based on Pearson’s x2 test.
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Table 2 Unadjusted and adjusted hazard ratios comparing subjects with J-point elevation in any lead to those without
J-point elevation
Sudden cardiac death HR (95% CI) Fatal/non-fatal CHD HR (95% CI) All-cause mortality HR (95% CI)
Unadjusted model 2.28 (1.69–3.07) 1.46 (1.28–1.65) 1.40 (1.28–1.53)
Model 1a 1.31 (0.94–1.82)d,e 1.06 (0.92–1.21)e 1.05 (0.96–1.16)
Model 2b 1.28 (0.90–1.82)d,e 1.06 (0.92–1.23)e 1.06 (0.96–1.18)
Model 3c 1.23 (0.87–1.75)d,e 1.03 (0.89–1.19)e 1.02 (0.92–1.13)
aCox’s proportional hazards model, adjusted for age, sex, and race.
bCox’s proportional hazards model, adjusted for age, sex, race, heart rate, systolic blood pressure, BMI, serum low-density lipoprotein, diabetes, presence of major ECG
abnormality, Cornell’s voltage for LVH, previous CHD, and history of angina or stroke.
cCox’s proportional hazards model, adjusted for age, sex, race, heart rate, systolic blood pressure, BMI, serum low-density lipoprotein, diabetes, presence of major ECG
abnormality, Cornell’s voltage for LVH, previous CHD, history of angina or stroke, smoking status, physical activity, and serum potassium.
dSignificant race interaction present (see Table 3 for stratified HRs).
eSignificant sex interaction present (see Table 3 for stratified HRs).
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increased risk among whites and females. The largely consistent
directionality of these effects decreases the probability that the
results were due to chance.
In this study, we examined the ECG finding of JPE, defined as a
J-point amplitude ≥0.1 mV in any lead. Although JPE is closely
related to early repolarization, they are not equivalent. J-point
elevation can be present even in the absence of the early repolar-
ization pattern, but early repolarization cannot be diagnosed
without its central feature of JPE.27 This partially explains why
the exposure prevalence in this study (12.3%) was higher than
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Table 4 Sudden cardiac death event rates, overall, and stratified by race and by sex
Total subjects in
stratum
J-point elevation # (%) SCD events among
exposed
No J-point elevation # (%) SCD events among
unexposed
Overall 15 141 1866 (12.3) 53 13 275 (87.7) 181
Race
White 11 068 871 (7.9) 24 10 197 (92.1) 113
Black 4073 995 (24.4) 32 3078 (75.6) 68
Sex
Female 8434 446 (5.3) 13 7988 (94.7) 62
Male 6707 1420 (21.2) 43 5287 (78.8) 119
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Table 5 Multivariate-adjusted hazard ratiosa comparing subjects with J-point elevation in any lead to subjects without
J-point elevation, stratified by race and sex simultaneously
White males HR
(95% CI) (n 5 5180)
White females HR
(95% CI) (n 5 5888)
Black males HR
(95% CI) (n 5 1527)
Black females HR
(95% CI) (n 5 2546)
Sudden cardiac death 1.51 (0.91–2.52) 8.77 (3.19–24.13) 0.82 (0.47–1.47) 1.33 (0.59–3.01)
Fatal/non-fatal CHD 1.11 (0.90–1.37) 1.32 (0.77–2.25) 0.80 (0.62–1.04) 1.47 (1.03–2.09)
All-cause mortality 1.14 (0.97–1.35) 0.93 (0.61–1.39) 0.94 (0.79–1.12) 0.96 (0.74–1.25)
aBased on Model 3: Cox’s proportional hazards model, adjusted for age, sex, race, heart rate, systolic blood pressure, BMI, serum low-density lipoprotein, diabetes, presence of
major ECG abnormality, Cornell’s voltage for LVH, previous CHD, history of angina or stroke, smoking status, physical activity, serum potassium, an interaction term between
J-point elevation status and race, and an interaction term between J-point elevation status and sex.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 3 Multivariate-adjusted hazard ratiosa comparing subjects with J-point elevation in any lead to subjects without
J-point elevation, stratified by race and by sex
Sudden cardiac death HR (95% CI) Fatal/non-fatal CHD HR (95% CI) All-cause mortality HR (95% CI)
Race
White 2.03 (1.28–3.21)b 1.16 (0.95–1.40) 1.10 (0.95–1.28)
Black 0.82 (0.52–1.30)b 0.91 (0.74–1.12) 0.96 (0.83–1.10)
Ratio of hazard ratios 2.46 1.27 1.15
Sex
Female 2.54 (1.34–4.82)b 1.47 (1.10–1.96)b 0.96 (0.77–1.19)
Male 1.02 (0.69–1.50)b 0.94 (0.80–1.11)b 1.04 (0.92–1.16)
Ratio of hazard ratios 2.50 1.55 0.92
aBased on Model 3: Cox’s proportional hazards model, adjusted for age, sex, race, heart rate, systolic blood pressure, BMI, serum low-density lipoprotein, diabetes, presence of
major ECG abnormality, Cornell’s voltage for LVH, previous CHD, history of angina or stroke, smoking status, physical activity, and serum potassium. For the analysis by race,
Model 3 included an interaction term for the significant interaction between J-point elevation status and race. For the analysis by sex, Model 3 included an interaction term for the
significant interaction between J-point elevation status and sex.
bP-value for interaction ,0.05.
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that observed in most previous studies, though a recent population
based study found a 13.1% prevalence of early repolarization.8 –11
Additionally, we included leads V1–V3, whereas these leads are fre-
quently omitted in studies of early repolarization in an effort to
exclude subjects with Brugada’s syndrome.5,14,28 However, Bruga-
da’s syndrome has also been reported in the inferior leads.29,30
Because we wished to examine the prognostic significance of JPE
in any lead regardless of the aetiology behind this elevation,
leads V1–V3 were not excluded.
In addition to differences in the studied exposure, differences
in cohort characteristics between this study and previous studies
may explain the discrepancies in results. If JPE does indeed
connote increased risk in whites but not in blacks, then it is
not surprising that a cohort which was likely to be largely
white showed a significant overall relationship.10 The fact that
our cohort is 27% black is a strength of the study in terms of
its generalizability, but may mask a differential effect based on
race when analysis is not stratified.
Figure 2 Kaplan–Meier survival curves for sudden cardiac death in white subjects with and without J-point elevation, stratified by sex.
Figure 3 Kaplan–Meier survival curves for sudden cardiac death in black subjects with and without J-point elevation, stratified by sex.
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Another strength of the study is the process used for ascertain-
ment of SCD events. The SCD outcome was ascertained through a
strict adjudication process, providing a more accurate definition of
SCD than is often available in epidemiological studies. Limits to the
retrospective adjudication process certainly exist; however, we are
confident that the adjudication process provided a more valid and
reliable measure of SCD than that provided by the often-used
time-based definitions.
A further strength of this study is the integrity of the J-point
amplitude data. The J-point amplitude measurement is based on
a computer algorithm that produces highly repeatable measure-
ments and eliminates inter-reader variability. The use of the com-
puterized measurements also virtually removes intra-reader
variability with a repeatability of 100% and variability of 0%. This
contrasts with studies of early repolarization in which the subjec-
tive judgement of the ECG reader is a factor and varying definitions
of early repolarization are used between studies.27
Despite the large size of the cohort, relatively few SCD events
occurred in our study. In addition, few subjects manifested JPE in
the inferior and lateral ECG leads. Therefore, very few SCD
events occurred in these groups. Estimates of the effects in
these lead groupings are somewhat unstable, and thus, it is difficult
to draw conclusions about patterns in these lead groupings. In
addition, this study included only individuals between the ages of
45 and 64 years. Therefore, caution must be exercised in extending
conclusions to individuals outside this age range.
Our study shows that JPE may be an important marker of risk
for SCD in some populations. A link appears to exist between
JPE and ventricular arrhythmia, but this increased risk is likely to
be confined to certain subgroups. The trends found based on
sex and race in the present study merit further investigation.
Future research must also elucidate which other factors modulate
the risk associated with JPE in order to delineate which subgroups
of individuals with JPE are at significantly increased risk of SCD.
Ultimately, we must understand why these differences exist in
order to target strategies to prevent SCD in these higher-risk
individuals.
Supplementary material
Supplementary material is available at European Heart Journal
online.
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Living on an atrial kick—an unusual case of a stuck mitral valve
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A 53-year-old woman was admitted for dys-
pnoea. Her past history included mitral valve
replacement (mechanical, tilting disc) 20
years earlier. The patient was well coumadi-
nized both on admission and during the
previous months. X-ray demonstrated pul-
monary oedema. A transoesophageal echo
(TEE) study was preformed to evaluate a
high diastolic pressure gradient across the
prosthetic valve (Figure). The TEE findings
included an intermittent totally stuck mitral
valve with no flow at all and absent diastolic
filling during some of the beats. During the
other beats, a high velocity flow was demon-
strated only during late diastole, as a result of
the atrial contraction. Therefore, the entire
left ventricular filling and the resulting
cardiac output was totally dependent on
the atrial kick, highlighting the crucial impor-
tance of sinus rhythm in this patient. These
findings were further demonstrated in a 3D
echo (movie-1, Supplementary material).
The patient was referred for an emergency operation. A pannus was demonstrated to be the cause of the stuck valve and the
patient underwent a successful mitral valve replacement. A biological prosthetic valve was used due to the patient’s strict request.
Figure. A continuous wave Doppler imaging of the mitral valve inflow. A very high diastolic pressure gradient (peak 28 mmHg, mean
18 mmHg) is calculated, suggesting a stuck valve. During the first and the last beat in this figure (short arrows), the valve is totally stuck
and there is no flow at all. During the other 3 beats (arrows), the high velocity flow is demonstrated; however, it occurs only during
late systole, as a result of atrial contraction; however, early diastolic filling is completely absent. Therefore, the entire left ventricular
filling and the resulting cardiac output is totally dependent on the atrial kick.
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